Nodexus

What it does

"Nodexus is a pioneering health startup focused on democratizing access to live single cells for various applications, including gene editing and drug development. Developed at Princeton University and UC Berkeley, Nodexus has created a groundbreaking microfluidic technology that enhances the detection of circulating tumor cells (CTCs) responsible for cancer metastasis. Their patented platform is cost-effective, portable, and requires minimal sample preparation, delivering rapid and precise results. Unlike existing systems, Nodexus can identify various types of CTCs, revolutionizing cancer diagnostics. By shifting towards predictive and personalized medicine, Nodexus aims to empower healthcare professionals with real-time information for prompt treatment decisions. This innovative approach eliminates the delays associated with traditional diagnostic testing, ultimately improving patient outcomes."